Intellicheck, Inc. IDN Deferred Tax Liability, Research And Experimental Expense Capitalization
Deferred Tax Liability, Research And Experimental Expense Capitalization at other companies
Other financials
Where this comes from
Reported directly by Intellicheck, Inc. in its filing.
Tagged under the XBRL concept idn:DeferredTaxLiabilityResearchAndExperimentalExpenseCapitalization.
The official record: Intellicheck, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Intellicheck, Inc.'s deferred tax liability, research and experimental expense capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Intellicheck, Inc.'s deferred tax liability, research and experimental expense capitalization?
- Intellicheck, Inc. (IDN) reported deferred tax liability, research and experimental expense capitalization of $463K in Q4 2025.
- What does deferred tax liability, research and experimental expense capitalization mean?
- This represents the tax liability arising from the mandatory capitalization and amortization of research and experimental expenditures for tax reporting purposes. It reflects the timing difference between immediate expensing for financial accounting and the required multi-year deduction schedule for tax filings. Investors monitor this to understand future cash tax obligations resulting from current R&D investment strategies.